ClinicalTrials.govpublic full text
EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR)
nasopharyngeal carcinoma, ebv dna, biomarker-guided, treatment adaptation, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 839658
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.